it all starts with knowing what you own. penny stocks like

New Post Public Reply Private Reply Replies (1) Message Board
PowerPuncher Sunnybank #123

it all starts with knowing what you own. penny stocks like this do not come around very often. and people make mistakes in evaluating a previous holding, then carrying that baggage to other stocks. know what you own, it is the only way to make wise choices and decide how to leverage each opportunity.

i know more than a few holders with over 130million shares. the stock has no dilution, ungagged ta, and has come through some very bad times with incredible upside potential in a very real and new business. most are holding any core shares they purchase below a target price (like a penny, 1.5 or 1.75-2 cents) then they trade off their core holdings to reduce their cost average and to maximize tax benefit of holding shares for a year or more. the shares they trade now, they expect to set a no-trade timeline, or up the price target, as the company, business, developments and operations/progress warrants. that's how i am rolling here, that is my strategy

so no one can tell you what you should do. i haven't sold one share under my target 1.5 till news and then i will likely lift my target accordingly to 02-025 probably. i look to understand the business, decide the potential, look at the tax situation and i evaluate all stocks differently as no two are the same. this one is pretty unique in that they have the jv for financing and their are no dilutive issues (thats a very big deal as shorters can only try to target market cap and profit to exploit gains) and many nearly countless other reasons ill not address

basically, i am only trading shares i know i can re-buy for sure and avoiding selling shares i doubt will be around in the next 3-6mo because the long-term tax benefit offsets the short-term gain and cost averaging opportunity.

again, without dilution and the disastrous cumulative and exponential effects they have on a stock (especially where short selling is concerned) peeps need to know what they own, develop a strategy and stick to it.

this stock has .2-.3 written all over it in the next 2-3 years, at least that is what my research says and i am acting accordingly. i am so thrilled with this stock i can't even control myself, but everyone has to trade, invest, buy, sell or hold according to their intelligence, experience, wisdom and DD

sorry, can't and don't ever tell anyone what to do with their money. i know many who have sold sub-$01 shares and my research tells me that was a bad move. that doesn't mean the price will never, or was never to go there, and there are a ton of factors to consider too- like how big a position one is carrying. the lower price ranges will not really allow for re-loading large positions, so there is that to consider too and what factored into my plan, my strategy and comments here. this is a stock most will wish they built a very large position in when all is said and done. next year around this time, i bet we are looking at having broken up through $.1 and for folks who sold sub $01 positions (again considering tax elements) that is a huge amount of money LEFT ON THE TABLE.

SPO Networks, Inc. (SPOI) Stock Research Links

SPOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 510

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 341

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 510

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 475

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 128

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 105

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 65

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
China, Europe, Africa Team Up for Green Energy Push

Updated Category News Views 107

The Need for Unity in a Warming World Some folks out there might be scratching their heads, wondering what sparks are flying between China, Europe, and Africa this time. Well, during the 2026 China-Europe-Africa Green Energy Development Forum held in sunny Zhejiang, the theme was loud and clear: We've got to deepen green partnerships to build a zero-carbon future. They're...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 77

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 745

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Penns Woods Banco Achieves New Stock Milestone of $24.25

Updated Category News Views 69

Penns Woods Banco Hits a 52-Week High Stock Price Penns Woods Banco Inc. (PWOD) has recently made headlines in the financial world by reaching a notable milestone with its stock price hitting a 52-week high of $24.25. This achievement is more than just a number; it represents a significant accomplishment for the regional bank holding company, which has witnessed a...

Continue Reading
Deep Dive into Recent Trends in Wolfspeed's Short Selling Landscape

Updated Category News Views 690

Wolfspeed’s Short Interest Is Climbing Wolfspeed (WOLF) has seen a clear pickup in short interest, rising 12.72% since the last read. The latest tally shows 24.14 million shares sold short, equal to 26.5% of the shares available to trade. One more useful measure: at current trading volumes, it would take about 5.76 days on average for short sellers to buy back those...

Continue Reading
Google Integrates SandboxAQ's Powerful AI for Quantum Progress

Updated Category News Views 173

Google Collaborates with SandboxAQ for Advanced AI Models In an exciting development in the realm of artificial intelligence, Google Cloud has partnered with SandboxAQ, a distinguished quantum startup. This collaboration aims to enhance Google's cloud services by integrating SandboxAQ's large quantitative models (LQMs), designed to manage extensive numerical data, execute...

Continue Reading
Will Gold Soar Further? Analyzing Market Influences

Updated Category News Views 154

Gold Grows Despite the Higher-Than-Expected US CPI Data Gold experienced a notable upswing, reversing its previous bearish trend during a trading session influenced by rising US inflation data. The XAU/USD pair gained 0.87% even as the US dollar saw strength from the latest Consumer Price Index (CPI) report. Market dynamics such as geopolitical uncertainty and...

Continue Reading
NRx Pharmaceuticals Engages Investors at Global Conference

Updated Category News Views 129

NRx Pharmaceuticals Shares Insights at Investment Conference Wilmington, Delaware — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a dedicated clinical-stage biopharmaceutical company focused on groundbreaking treatments, is set to participate in an engaging fireside chat at the highly anticipated H.C. Wainwright's 27th Annual Global Investment Conference. Event Details and...

Continue Reading